Cambridge Investment Research Advisors’s Innovator Equity Defined Protection ETF - 1 Yr November ZNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.48M Sell
345,378
-20,106
-6% -$547K 0.02% 699
2026
Q1
$9.7M Buy
365,484
+50,711
+16% +$1.36M 0.03% 636
2025
Q4
$8.4M Buy
314,773
+304,353
+2,921% +$8.08M 0.02% 658
2025
Q3
$275K Buy
+10,420
New +$272K ﹤0.01% 3186
2025
Q1
Sell
-198,716
Closed -$4.99M 3662
2024
Q4
$4.99M Buy
+198,716
New +$4.99M 0.02% 806

Other funds holding ZNOV

Cambridge Investment Research Advisors's ZNOV Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Innovator Equity Defined Protection ETF - 1 Yr November (ZNOV) stake by 5.5% in Q2 2026, selling an estimated $547K and leaving 345,378 shares worth $9.48M. The position accounts for 0.02% of the portfolio, ranked #699.

Cambridge Investment Research Advisors first reported a position in ZNOV in Q4 2024 and has held it in 5 quarters since. The position peaked at $9.7M in Q1 2026. 28 funds tracked by Wall St. Rank hold ZNOV as of Q2 2026.

  • Cambridge Investment Research Advisors held 345,378 shares of Innovator Equity Defined Protection ETF - 1 Yr November worth $9.48M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 20,106 Innovator Equity Defined Protection ETF - 1 Yr November shares in Q2 2026, an estimated $547K.
  • Innovator Equity Defined Protection ETF - 1 Yr November made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #699 holding.
  • Cambridge Investment Research Advisors first reported a position in Innovator Equity Defined Protection ETF - 1 Yr November in Q4 2024 and has held it in 5 quarters since.
  • Cambridge Investment Research Advisors's Innovator Equity Defined Protection ETF - 1 Yr November position peaked at $9.7M in Q1 2026.
  • 28 funds tracked by Wall St. Rank held Innovator Equity Defined Protection ETF - 1 Yr November as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.